Health and Fitness

FDA Approves Xermelo for Carcinoid Syndrome Diarrhea

February 28, 2017 Press 0

Silver Spring, Maryland–(ENEWSPF)–February 28, 2017.  The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA …READ MORE